Low noise patch-clamp current amplification by nanoparticles plasmonic-photonic coupling (analysis and modelling).
In this article, a patch-clamp low noise current amplification based on nanoparticles plasmonic radiation is analyzed. It is well-known, a very small current is flowing from different membrane channels and so, for extra processing the current amplification is necessary. It is notable that there are some problems in traditional electronic amplifier due to its noise and bandwidth problem. Because of the important role of the patch-clamp current in cancer research and especially its small amplitude, it is vital to intensify it without adding any noises. In this study, the current amplification is performed firstly: from the excitement of nanoparticles by the patch-clamp pico-ampere current and then, the effect of nanoparticles plasmonic far-field radiation on conductor's carriers, which will cause the current amplification. This relates to the plasmonic-photonic coupling and their effect on conductor carriers as the current perturbation agent. In the steady state, the current amplification can reach to 1000 times of initial level. Furthermore, we investigated the nanoparticles morphology changing effect such as size, nanoparticles inter-distance, and nanoparticles distance from the conductor on the amplifier parameters. Finally, it should note that the original aim is to use nanoparticles plasmonic engineering and their coupling to photonics for output current manipulating.
Baskent University, Department of Biomedical Engineering, 06800, Ankara, Angora, Turkey.
E O
EO
Haberal
Electrical Engineering Department, Tabriz University, 51666, Tabriz, Iran. tirdad.zey@gmail.com.
A
A
SalmanOgli
Hacettepe University, Chemical Engineering Department, Bioengineering Division, 06800, Ankara, Turkey.
B
B
Nasseri
IEEE Trans Biomed Eng. 2013 May;60(5):1328-35
23268375
Methods Enzymol. 1998;293:218-66
9711612
Pflugers Arch. 1978 Jul 18;375(2):219-28
567789
Biophys J. 1993 Oct;65(4):1666-77
7506069
Pflugers Arch. 1981 Aug;391(2):85-100
6270629
Opt Express. 2009 Mar 2;17(5):3741-53
19259215